Phase 1 Advanced Solid Malignant Tumor Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)

Shenzhen University General Hospital20 enrolled1 locationNCT07399769

Recruiting

Phase 1Phase 2

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Small Cell Lung CancerAdvanced Solid Malignant Tumor

Chipscreen Biosciences, Ltd.36 enrolled11 locationsNCT05271292